MKHHHHHHASGRADPHSLCYDITVIPKFRPGPRWCAVQGQVDEKTFLHYD CGNKTVTPVSPLGKKLNVTTAWKAQNPVLREVVDILTEQLRDIQLENYTP KEPLTLQARMSCEQKAEGHSSGSWQFSFDGQIFLLFDSEKRMWTTVHPGA RKMKEKWENDKVVAMSFHYFSMGDCIGWLEDFLMGMDSTLEPSAGAPLAM S
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
< 1.000 Eu/µg
>90% by SDS-PAGE.
Concentration information loading...
Preparation and Storage
Stability and Storage
Shipped at 4°C. Store at -80°C. Avoid freeze / thaw cycle.
pH: 8.6 Constituent: Tris buffer
0.4 µm filtered prior to lyophilization.
Add 200 µl of deionized water allow the lyophilized pellet dissolve completely.
NKG2D ligand 2
NKG2D ligand 2 precursor
Retinoic acid early transcript 1 H
Retinoic acid early transcript 1H
UL16 binding protein 2
UL16-binding protein 2
Ligand for the NKG2D receptor, together with at least ULBP1 and ULBP3. ULBPs activate multiple signaling pathways in primary NK cells, resulting in the production of cytokines and chemokines. Binding of ULBPs ligands to NKG2D induces calcium mobilization and activation of the JAK2, STAT5, ERK and PI3K kinase/Akt signal transduction pathway. In CMV infected cells, interacts with soluble CMV glycoprotein UL16. The interaction with UL16 blocked the interaction with the NKG2D receptor, providing a mechanism by which CMV infected cells might escape the immune system. UL16 also causes ULBP2 to be retained in the ER and cis-Golgi apparatus so that it does not reach the cell surface.
Expressed in various types of cancer cell lines and in the fetus, but not in normal tissues.